Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  SIX SWISS EXCHANGE AG  >  Roche Holding Ltd.       CH0012032048

Financials ( CHF)
Sales 2016 51 232 M
EBIT 2016 17 991 M
Net income 2016 11 251 M
Debt 2016 10 952 M
Yield 2016 3,54%
Sales 2017 53 839 M
EBIT 2017 19 243 M
Net income 2017 12 701 M
Debt 2017 5 248 M
Yield 2017 3,75%
P/E ratio 2016 18,18
P/E ratio 2017 16,26
EV / Sales2016 4,29x
EV / Sales2017 3,97x
Capitalization 208 744 M
More Financials
Roche Holding AG operates as a research healthcare company.It operates through the diagnostics and pharmaceuticals segments.The pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience.The diagnostic segment... 
10/20 | 07:00amSales and Revenue Release
More about the company
Surperformance© ratings of Roche Holding Ltd.
Trading Rating : Investor Rating :
More Ratings
Latest news on ROCHE HOLDING LTD.
09/29 CHUGAI PHARMACEUTICAL : Findings from Chugai Pharmaceutical Provides New Data on..
09/29 CHUGAI PHARMACEUTICAL : Findings from Chugai Pharmaceutical Broaden Understandin..
09/29 TRANSGENOMIC : and Ventana Medical Systems Complete Data Sharing Agreement
09/29 CHUGAI PHARMACEUTICAL : and Maruho Announce License Agreement of Nemolizumab (CI..
09/29 ASTRAZENECA : Gets US Approval For Tagrisso Companion Diagnostic Test
09/26 HERE’S A LOOK AT AC IMMUNE LTD : ACIU)’s Alzheimer’s Candidate..
09/25 CURIS : Aurigene to Invest in Curis at Premium Through Waiver of Certain Milesto..
09/25 ROCHE : MILITARY $99,980 Federal Contract Awarded to Roche Diagnostics
09/23 GLOBAL BLOOD GLUCOSE TEST STRIPS MAR : Roche, Lifescan, Bayer, Abbott, ARKRAY, I..
09/23 MEDICINES : HHS forges strategic partnerships with two global companies to devel..
More news
Sector news : Pharmaceuticals - NEC
07:26aDJNovo Nordisk Announces Job Cuts
09/29DJGLAXOSMITHKLINE : Appoints New Consumer Healthcare Chief
09/29DJNOVO NORDISK A/S : to Cut 1,000 Jobs Amid Growing Competition -- Update
09/28DJINTRA CELLULAR THERAPIES : Shares Plunge After Disappointing Drug Trial Results
09/28DJGLAXOSMITHKLINE : to Sell Remaining 6.2% Stake in Aspen Pharmacare
More sector news : Pharmaceuticals - NEC
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 297  CHF
Spread / Average Target 23%
Consensus details
EPS Revisions
More Estimates Revisions
Severin Schwan Chief Executive Officer & Executive Director
Christoph Franz Chairman
Daniel O'Day COO-Roche Pharmaceuticals Division
Roland Diggelmann COO-Roche Diagnostics Division
Alan Hippe Chief Financial & Information Technology Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON14.16%320 836
ROCHE HOLDING LTD.-11.51%216 029
NOVARTIS AG-10.14%209 049
PFIZER INC.3.22%202 108
MERCK & CO., INC.17.21%171 194
More Results